Haloperidol and Budesonide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Haloperidol (haloperidol) and Budesonide (budesonide). Common drug interactions include neuropathy peripheral among females and sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Haloperidol and Budesonide. It is created by eHealthMe based on reports of 95 people who take the same drugs from the FDA, and is updated regularly.

What is Haloperidol?

Haloperidol has active ingredients of haloperidol. It is often used in schizophrenia. eHealthMe is studying from 16,637 Haloperidol users. Check the latest studies of Haloperidol.

What is Budesonide?

Budesonide has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 42,933 Budesonide users. Check the latest studies of Budesonide.



On Jul, 15, 2026

95 people who take Haloperidol and Budesonide together, and have interactions are studied.

Haloperidol and Budesonide drug interactions.

What are the common drug interactions of Haloperidol and Budesonide, by gender? *:

female:

  1. Neuropathy peripheral (surface nerve damage)
  2. Upper respiratory tract infection
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Pyrexia (fever)
  5. Dyspnoea (difficult or laboured respiration)
  6. Electrolyte imbalance
  7. Septic shock (shock due to blood infection)
  8. Psychomotor hyperactivity (feelings of extreme restlessness)
  9. Death
  10. Haemodynamic instability (disturbances in the blood movement in our body)

male:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  3. Multi-organ failure (multisystem organ failure)
  4. Pneumonia
  5. Renal failure (kidney dysfunction)
  6. Device dislocation
  7. Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)
  8. Weight gain poor
  9. 5-hydroxyindolacetic acid in urine decreased (decreased serotonin levels in urine)
  10. Abdominal distension

What are the common drug interactions of Haloperidol and Budesonide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Device dislocation
  2. Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)
  3. Weight gain poor
  4. Altered state of consciousness (altered state of mind)
  5. Hydrocephalus (water on the brain)
  6. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  7. Subdural haematoma (blood collects between the skull and the surface of the brain)

10-19:

  1. Haematemesis (vomiting of blood)

20-29:

  1. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)

30-39:

  1. Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
  2. Dyspnoea (difficult or laboured respiration)
  3. Hypotension (abnormally low blood pressure)
  4. Psychomotor hyperactivity (feelings of extreme restlessness)
  5. Pyrexia (fever)
  6. Hypoxia (low oxygen in tissues)
  7. Breath sounds
  8. Haemodynamic instability (disturbances in the blood movement in our body)
  9. Sputum purulent

40-49:

  1. Cellulitis (infection under the skin)
  2. Abdominal sepsis (abdominal infection)
  3. Escherichia infection (bacterial infection by escherichia coli)
  4. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Enterococcal infection
  7. Haematoma (collection of blood outside the blood vessels)
  8. Haemoglobin decreased
  9. Laceration (tearing of soft body tissue)
  10. Melaena (the passage of black, tarry stools)

50-59:

  1. Dyskinesia (abnormality or impairment of voluntary movement)
  2. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  3. General physical health deterioration (weak health status)
  4. International normalised ratio decreased
  5. Malignant neoplasm progression (cancer tumour came back)
  6. Mass
  7. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  8. Pain in extremity
  9. Renal failure (kidney dysfunction)
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

60+:

  1. Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
  2. Renal failure (kidney dysfunction)
  3. Abdominal distension
  4. Anxiety
  5. General physical health deterioration (weak health status)
  6. Hypotension (abnormally low blood pressure)
  7. Livedo reticularis (a lace-like purplish discoloration of the skin)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)
  9. Serotonin syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time)
  10. Apallic syndrome (serious brain damage, when cortical parts of the brain are disconnected from brainstem)

What are the existing conditions these people have? *

  1. Insomnia (sleeplessness): 17 people, 17.89%
  2. Stress And Anxiety: 15 people, 15.79%
  3. Neuropathy Peripheral (surface nerve damage): 15 people, 15.79%
  4. Breast Cancer Metastatic: 13 people, 13.68%
  5. Upper Respiratory Tract Infection: 11 people, 11.58%
  6. Pain: 10 people, 10.53%
  7. Infection: 8 people, 8.42%
  8. Pulmonary Embolism (blockage of the main artery of the lung): 7 people, 7.37%
  9. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 7 people, 7.37%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 7.37%

* Approximation only. Some reports may have incomplete information.

Do you take Haloperidol and Budesonide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Haloperidol and Budesonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Haloperidol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Budesonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Haloperidol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Budesonide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on haloperidol and budesonide (the active ingredients of Haloperidol and Budesonide, respectively), and Haloperidol and Budesonide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: